JP2000178201A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000178201A5 JP2000178201A5 JP1999358587A JP35858799A JP2000178201A5 JP 2000178201 A5 JP2000178201 A5 JP 2000178201A5 JP 1999358587 A JP1999358587 A JP 1999358587A JP 35858799 A JP35858799 A JP 35858799A JP 2000178201 A5 JP2000178201 A5 JP 2000178201A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fibrin
- composition according
- adhesive
- fibrin glue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 10
- 239000008194 pharmaceutical composition Substances 0.000 description 9
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19858463:6 | 1998-12-18 | ||
| DE19858463A DE19858463A1 (de) | 1998-12-18 | 1998-12-18 | Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000178201A JP2000178201A (ja) | 2000-06-27 |
| JP2000178201A5 true JP2000178201A5 (https=) | 2006-12-14 |
Family
ID=7891554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11358587A Pending JP2000178201A (ja) | 1998-12-18 | 1999-12-17 | 組織再生に対するフィブリン接着剤の使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1016415A3 (https=) |
| JP (1) | JP2000178201A (https=) |
| KR (1) | KR20000057069A (https=) |
| AU (1) | AU6528899A (https=) |
| CA (1) | CA2292481A1 (https=) |
| DE (1) | DE19858463A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6979307B2 (en) | 1997-06-24 | 2005-12-27 | Cascade Medical Enterprises Llc | Systems and methods for preparing autologous fibrin glue |
| US7745106B2 (en) | 1997-06-24 | 2010-06-29 | Cascade Medical Enterprises, Llc | Methods and devices for separating liquid components |
| EP1089520A3 (en) * | 1999-09-28 | 2003-06-25 | AT&T Corp. | H.323 User, service and service provider mobility framework for the multimedia intelligent networking |
| JP4875299B2 (ja) * | 2002-06-27 | 2012-02-15 | ベレッタ ロベルト | 液体成分を分離する方法及び装置 |
| CN111032604B (zh) | 2017-10-19 | 2020-10-30 | 美国陶氏有机硅公司 | 含有可用作氢化硅烷化反应抑制剂的2-取代的-1-炔基-1-环己醇的聚有机硅氧烷组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6013619A (en) * | 1988-01-06 | 2000-01-11 | The Scripps Research Institute | Pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| CN1091315A (zh) * | 1992-10-08 | 1994-08-31 | E·R·斯奎布父子公司 | 血纤维蛋白封闭剂组合物及其使用方法 |
| US5817303A (en) * | 1995-05-05 | 1998-10-06 | Protein Polymer Technologies, Inc. | Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
-
1998
- 1998-12-18 DE DE19858463A patent/DE19858463A1/de not_active Withdrawn
-
1999
- 1999-12-11 EP EP99124688A patent/EP1016415A3/de not_active Withdrawn
- 1999-12-16 CA CA002292481A patent/CA2292481A1/en not_active Abandoned
- 1999-12-17 KR KR1019990058617A patent/KR20000057069A/ko not_active Ceased
- 1999-12-17 JP JP11358587A patent/JP2000178201A/ja active Pending
- 1999-12-17 AU AU65288/99A patent/AU6528899A/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004524278A5 (https=) | ||
| CA2246332A1 (en) | Catheter based surgery | |
| US8771663B2 (en) | Formulation having mobilising activity | |
| RU2002127804A (ru) | Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения | |
| EA200501420A1 (ru) | Устройство доставки для лекарственной и клеточной терапии | |
| WO2004024209A3 (en) | Materials and methods for drug delivery and uptake | |
| JP2003501361A5 (https=) | ||
| JP2009535309A5 (ja) | 医薬製剤の生産方法およびその方法により生産される医薬製剤 | |
| JP2011173904A (ja) | カルボニルストレス改善剤 | |
| Sadrzadeh et al. | Peptide drug delivery strategies for the treatment of diabetes | |
| WO1999056723A3 (en) | Hemoglobine-haptoglobin complexes for targeted drug delivery | |
| JP2000178201A5 (https=) | ||
| JP2002524421A5 (https=) | ||
| JP2001511463A5 (https=) | ||
| CA2444391A1 (en) | Methods and devices for administration of substances into the intradermal layer of skin for systemic absorption | |
| JP2002530353A5 (https=) | ||
| AU3024389A (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
| CA2406179C (en) | Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors | |
| JP2003501345A5 (https=) | ||
| ATE301452T1 (de) | Verfahren zur herstellung einer flüssigen dosierungseinheit und kit | |
| EP1637152A8 (en) | A notoginseng saponin intravenous injection and the method for preparing this injection | |
| JP2004527465A5 (https=) | ||
| EP1016415A3 (de) | Verwendung eines Fibrinklebers zur Geweberegeneration | |
| JPS63120609U (https=) | ||
| JP2002529515A5 (https=) |